share_log

Cantor Fitzgerald Reinstates Neutral on TherapeuticsMD, Announces $5 Price Target

Benzinga Real-time News ·  Jan 11, 2023 07:47

Cantor Fitzgerald analyst Louise Chen reinstates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment